Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

New generation multi-modal antidepressants: focus on vortioxetine for major depressive disorder.

Katona CL, Katona CP.

Neuropsychiatr Dis Treat. 2014 Feb 19;10:349-54. doi: 10.2147/NDT.S39544. eCollection 2014. Review.

2.

Efficacy of memantine on behavioral and psychological symptoms related to dementia: a systematic meta-analysis.

Maidment ID, Fox CG, Boustani M, Rodriguez J, Brown RC, Katona CL.

Ann Pharmacother. 2008 Jan;42(1):32-8. Epub 2007 Dec 4.

PMID:
18056833
3.

Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.

Walker Z, Jaros E, Walker RW, Lee L, Costa DC, Livingston G, Ince PG, Perry R, McKeith I, Katona CL.

J Neurol Neurosurg Psychiatry. 2007 Nov;78(11):1176-81. Epub 2007 Mar 12.

4.

Caregivers' experience of risk in dementia: the LASER-AD study.

Walker AE, Livingston G, Cooper CA, Katona CL, Kitchen GL.

Aging Ment Health. 2006 Sep;10(5):532-8.

PMID:
16938688
5.

Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study.

Livingston G, Walker AE, Katona CL, Cooper C.

J Neurol Neurosurg Psychiatry. 2007 Jan;78(1):25-9. Epub 2006 Jun 26.

6.

Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison.

Walker Z, Costa DC, Walker RW, Lee L, Livingston G, Jaros E, Perry R, McKeith I, Katona CL.

Neurology. 2004 May 11;62(9):1568-72.

PMID:
15136683
7.

Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand.

Walker Z, Costa DC, Walker RW, Shaw K, Gacinovic S, Stevens T, Livingston G, Ince P, McKeith IG, Katona CL.

J Neurol Neurosurg Psychiatry. 2002 Aug;73(2):134-40.

8.

Psychotropics and drug interactions in the elderly patient.

Katona CL.

Int J Geriatr Psychiatry. 2001 Dec;16 Suppl 1:S86-90.

PMID:
11748792
9.

Post-mortem studies of brain phosphatidylinositol hydrolysis in depression and the effect of antidepressant treatment.

Coull MA, Lowther S, Katona CL, Horton RW.

Int J Neuropsychopharmacol. 2000 Jun;3(2):109-115.

PMID:
11343587
10.

Altered brain protein kinase C in depression: a post-mortem study.

Coull MA, Lowther S, Katona CL, Horton RW.

Eur Neuropsychopharmacol. 2000 Jul;10(4):283-8.

PMID:
10871711
11.

Three years survival in patients with a clinical diagnosis of dementia with Lewy bodies.

Walker Z, Allen RL, Shergill S, Mullan E, Katona CL.

Int J Geriatr Psychiatry. 2000 Mar;15(3):267-73. Review.

PMID:
10713586
12.

Outcome in refractory depression.

Shergill SS, Robertson MM, Stein G, Bernadt M, Katona CL.

J Affect Disord. 1999 Aug;54(3):287-94.

PMID:
10467973
13.

In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies.

Walker Z, Costa DC, Ince P, McKeith IG, Katona CL.

Lancet. 1999 Aug 21;354(9179):646-7.

PMID:
10466669
14.

Olanzapine in dementia with Lewy bodies: a clinical study.

Walker Z, Grace J, Overshot R, Satarasinghe S, Swan A, Katona CL, McKeith IG.

Int J Geriatr Psychiatry. 1999 Jun;14(6):459-66.

PMID:
10398356
15.
16.

[3H] imipramine binding in brain samples from depressed suicides and controls: 5-HT uptake sites compared with sites defined by desmethylimipramine.

Lawrence KM, Kanagasundaram M, Lowther S, Katona CL, Crompton MR, Horton RW.

J Affect Disord. 1998 Jan;47(1-3):105-12.

PMID:
9476750
17.

Neuropsychological and imaging differences in dementia with Lewy bodies and Alzheimer's disease.

Allen RL, Walker Z, Katona CL.

Br J Psychiatry. 1997 Nov;171:486-7. No abstract available.

PMID:
9463621
18.

Dopamine uptake sites, labelled with [3H]GBR12935, in brain samples from depressed suicides and controls.

Bowden C, Cheetham SC, Lowther S, Katona CL, Crompton MR, Horton RW.

Eur Neuropsychopharmacol. 1997 Nov;7(4):247-52.

PMID:
9443655
19.

Corticotropin-releasing factor binding sites in cortex of depressed suicides.

Hucks D, Lowther S, Crompton MR, Katona CL, Horton RW.

Psychopharmacology (Berl). 1997 Nov;134(2):174-8.

PMID:
9399381
20.

Geriatric depression scale can be used in older people in primary care.

Katona CL, Katona PM.

BMJ. 1997 Nov 8;315(7117):1236. No abstract available.

21.

Reduced dopamine turnover in the basal ganglia of depressed suicides.

Bowden C, Cheetham SC, Lowther S, Katona CL, Crompton MR, Horton RW.

Brain Res. 1997 Sep 19;769(1):135-40.

PMID:
9374281
22.

5-HT1D and 5-HT1E/1F binding sites in depressed suicides: increased 5-HT1D binding in globus pallidus but not cortex.

Lowther S, Katona CL, Crompton MR, Horton RW.

Mol Psychiatry. 1997 Jul;2(4):314-21.

23.

Dementia with lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon emission tomography.

Walker Z, Costa DC, Janssen AG, Walker RW, Livingstone G, Katona CL.

Eur J Nucl Med. 1997 Jun;24(6):609-14.

PMID:
9169566
24.

Brain [3H]cAMP binding sites are unaltered in depressed suicides, but decreased by antidepressants.

Lowther S, Katona CL, Crompton MR, Horton RW.

Brain Res. 1997 May 30;758(1-2):223-8.

PMID:
9203552
25.

Brain alpha-adrenoceptors in depressed suicides.

De Paermentier F, Mauger JM, Lowther S, Crompton MR, Katona CL, Horton RW.

Brain Res. 1997 May 16;757(1):60-8.

PMID:
9200499
26.

Brain 5-hydroxytryptamine uptake sites labeled with [3H]paroxetine in antidepressant drug-treated depressed suicide victims and controls.

Lawrence KM, De Paermentier F, Lowther S, Crompton MR, Katona CL, Horton RW.

J Psychiatry Neurosci. 1997 May;22(3):185-91.

27.

Dopamine D1 and D2 receptor binding sites in brain samples from depressed suicides and controls.

Bowden C, Theodorou AE, Cheetham SC, Lowther S, Katona CL, Crompton MR, Horton RW.

Brain Res. 1997 Mar 28;752(1-2):227-33.

PMID:
9106461
28.

Pharmacological choices after one antidepressant fails: a survey of UK psychiatrists.

Shergill SS, Katona CL.

J Affect Disord. 1997 Mar;43(1):19-25.

PMID:
9127827
29.

5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls.

Lowther S, De Paermentier F, Cheetham SC, Crompton MR, Katona CL, Horton RW.

J Affect Disord. 1997 Feb;42(2-3):199-207.

PMID:
9105961
30.

Neuropsychological performance in Lewy body dementia and Alzheimer's disease.

Walker Z, Allen RL, Shergill S, Katona CL.

Br J Psychiatry. 1997 Feb;170:156-8.

PMID:
9093505
31.

Beta-adrenoceptors in human pineal glands are unaltered in depressed suicides.

De Paermentier F, Lowther S, Crompton MR, Katona CL, Horton RW.

J Psychopharmacol. 1997;11(4):295-9.

PMID:
9443516
32.

Unrecognized psychiatric illness in general practice.

Tullett DC, Orrell MW, Katona CL.

Br J Gen Pract. 1997 Jan;47(414):55-6. No abstract available.

33.

GTP gamma S and forskolin-stimulated adenylyl cyclase activity in post-mortem brain from depressed suicides and controls.

Lowther S, Crompton MR, Katona CL, Horton RW.

Mol Psychiatry. 1996 Dec;1(6):470-7.

PMID:
9154249
34.

Detecting and managing depression in older people.

Tylee A, Katona CL.

Br J Gen Pract. 1996 Apr;46(405):207-8. No abstract available.

35.

Predictors of response to amine-specific antidepressants.

Burns RA, Lock T, Edwards DR, Katona CL, Harrison DA, Robertson MM, Nairac B, Abou-Saleh MT.

J Affect Disord. 1995 Dec 13;35(3):97-106.

PMID:
8749837
36.

Risperidone for psychotic and behavioural symptoms in Lewy body dementia.

Allen RL, Walker Z, D'Ath PJ, Katona CL.

Lancet. 1995 Jul 15;346(8968):185. No abstract available.

PMID:
7541499
37.
38.

Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.

Katona CL, Abou-Saleh MT, Harrison DA, Nairac BA, Edwards DR, Lock T, Burns RA, Robertson MM.

Br J Psychiatry. 1995 Jan;166(1):80-6. Erratum in: Br J Psychiatry 1995 Apr;166(4):544.

PMID:
7894881
39.

Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine.

Lawrence KM, Katona CL, Abou-Saleh MT, Robertson MM, Nairac BL, Edwards DR, Lock T, Burns RA, Harrison DA, Horton RW.

Psychopharmacology (Berl). 1994 Jun;115(1-2):261-4.

PMID:
7862905
40.

Brain 5-HT2 receptors in suicide victims: violence of death, depression and effects of antidepressant treatment.

Lowther S, De Paermentier F, Crompton MR, Katona CL, Horton RW.

Brain Res. 1994 Apr 11;642(1-2):281-9.

PMID:
8032889
41.

A double-blind controlled comparison of fluoxetine and lofepramine in major depressive illness.

Robertson MM, Abou-Saleh MT, Harrison DA, Nairac BL, Edwards DR, Lock T, Burns RA, Katona CL.

J Psychopharmacol. 1994 Jan;8(2):98-103. doi: 10.1177/026988119400800205.

PMID:
22298536
42.

Approaches to the management of depression in old age.

Katona CL.

Gerontology. 1994;40 Suppl 1:5-9. Review.

PMID:
8020768
43.

NMDA glutamatergic receptors, labelled with [3H]MK-801, in brain samples from drug-free depressed suicides.

Holemans S, De Paermentier F, Horton RW, Crompton MR, Katona CL, Maloteaux JM.

Brain Res. 1993 Jul 9;616(1-2):138-43.

PMID:
8358605
44.

Effective and acceptable treatment for depression.

Robertson MM, Katona CL.

BMJ. 1993 Apr 24;306(6885):1125-6; author reply 1126-7. No abstract available.

45.

Growth hormone and physiological responses to clonidine in depression.

Katona CL, Healy D, Paykel ES, Theodorou AE, Lawrence KM, Whitehouse A, White B, Horton RW.

Psychol Med. 1993 Feb;23(1):57-63.

PMID:
8475215
46.

Sulpiride-induced tardive dyskinesia in a person with Gilles de la Tourette syndrome.

Eapen V, Katona CL, Barnes TR, Robertson MM.

J Psychopharmacol. 1993 Jan;7(3):290-2. doi: 10.1177/026988119300700309.

PMID:
22290844
47.

Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.

Katona CL, Robertson MM, Abou-Saleh MT, Nairac BL, Edwards DR, Lock T, Burns R, Harrison DA, Taylor NS.

Int Clin Psychopharmacol. 1993 Winter;8(4):323. No abstract available.

PMID:
8277156
48.

Psychiatric admissions and social deprivation: is the Jarman underprivileged area score relevant?

Cotgrove AJ, Bell G, Katona CL.

J Epidemiol Community Health. 1992 Jun;46(3):245-7.

49.

Depression and physical illness in the elderly.

Finch EJ, Ramsay R, Katona CL.

Clin Geriatr Med. 1992 May;8(2):275-87. Review.

PMID:
1600478
50.

Diagnosing Alzheimer's disease.

Butler RE, Costa DC, Ell PJ, Katona CL, Creco A.

BMJ. 1992 Feb 29;304(6826):574-5. No abstract available.

Supplemental Content

Loading ...
Support Center